| Similar Articles |
|---|
 |
The Motley Fool
September 24, 2008
Brian Orelli |
100% Results From Sequenom The company presents more data on its molecular diagnostic and buys a lab to run the tests in.   |
The Motley Fool
June 27, 2008
Brian Orelli |
The Right Time to Raise Capital After seeing its stock double in less than a month, thanks to some stellar preliminary results from its prenatal Down syndrome test, diagnostic-test maker Sequenom figured now was a perfect time to get some money into the coffers. |
The Motley Fool
November 30, 2010
Brian Orelli |
Better Buy: Exact Sciences or Sequenom? A battle of the diagnostic test makers. |
The Motley Fool
September 18, 2009
Brian Orelli |
Hey, Sequenom, That's Great, But ... Investors are still waiting for some real second-quarter news from Sequenom. |
The Motley Fool
January 30, 2009
Brian Orelli |
Sequenom Is a Rule Breaker Sequenom has potential; it wants to become the go-to place for molecular diagnostics. |
The Motley Fool
May 9, 2011
Brian Orelli |
Why Is Sequenom Up 20%? Investors appear to be overreacting. |
The Motley Fool
October 18, 2011
Brian Orelli |
How Not to Gain 75% of Your Company's Value Overnight A 75% increase in price certainly seems possible, but not until investors are convinced that Sequenom can execute on its sales plan the way it has on its clinical plan. |
The Motley Fool
May 8, 2010 |
Sequenom Restarting Development of Diagnostic Test for Down Syndrome The latest news at the San Diego-based biotech. |
The Motley Fool
June 3, 2010
Brian Orelli |
The Dragon That Cost Investors Millions The Securities and Exchange Commission filed a complaint against Elizabeth Dragon, the company's former Senior Vice President of Research and Development. |
The Motley Fool
December 31, 2008
Brian Orelli |
Health Care's Golden Children The whole industry wasn't down this year. |
American Family Physician
October 15, 2005 |
Prenatal Diagnosis: Amniocentesis and CVS An informational patient hand-out on these fetal diagnostic tests. |
The Motley Fool
February 18, 2009
Tim Beyers |
Stocks the Rich Executives Are Buying Sometimes insiders are buying for all the right reasons. Who's at it this week?: Seagate Technology... Prospect Capital... Interactive Intelligence... Sequenom... 99 Cents Only Stores... |
The Motley Fool
July 12, 2011
Brian Orelli |
Ducks in Order; Now Let's See Some Data Sequenom is getting all its ducks in a row in preparation for launching its SensiGene Trisomy 21 laboratory-developed test. |
The Motley Fool
July 27, 2010
Brian Orelli |
Better Buy: Cell Therapeutics or Sequenom? Which one deserves your dollars more? |
American Family Physician
August 15, 2000 |
Down Syndrome: What You Need to Know When You're Pregnant |
The Motley Fool
April 30, 2009
Brian Orelli |
How to Lose 75% of Your Company's Value Overnight Sequenom's shares sink 75% after the company said that four employees have been suspended because of "employee mishandling of R&D test data and results" for its revolutionary blood test for Down syndrome. |
The Motley Fool
February 8, 2011
Brian Orelli |
What Will Intuitive Surgical Do for an Encore? Intuitive Surgical managed just a 10% year-over-year increase in revenue from sales of its da Vinci Surgical Systems in the fourth quarter of last year. Yet its total revenue increased a solid 21%. How? |
The Motley Fool
September 30, 2009
Brian Orelli |
Call Me a Wimp, but I'm Still Nervous Can the mud Sequenom seems to be running in turn to quicksand? |
The Motley Fool
May 28, 2009
Anders Bylund |
Of Robots and Rocket-Powered Returns Intuitive Surgical is a stock that meets your need for speed and security, all at once. |
The Motley Fool
February 4, 2009
Devon Rackle |
An Intuitively Obvious Buy Virtually limitless growth, a monopolistic position, and a cheap valuation all make Intuitive Surgical a compelling opportunity. |
The Motley Fool
December 20, 2011
Brian Orelli |
What's Up With the Back-Slapping, Sequenom? Some sales numbers would be nice. |
The Motley Fool
August 15, 2011
Brian Orelli |
Another Partner, but Still No Data Sequenom signs up a European partner. |
Scientific American
February 2009
Charles Q. Choi et al. |
News Scan Briefs: Weak on the Nano Risk Also: Booby Traps for Bacteria and more... |
The Motley Fool
July 25, 2011
Brian Stoffel |
My Money Is On This Hot Medical Stock Intuitive Surgical is blazing new paths for surgical procedures. |
The Motley Fool
October 19, 2011
Brian Orelli |
This High-Tech Company Still Has the Touch Intuitive Surgical beats analysts' expectations. Again. |
The Motley Fool
October 19, 2007
Billy Fisher |
Defying Intuition at Intuitive Surgical Another round of good quarterly results brings another boost in surgical robot maker Intuitive Surgical's stock price. Investors, take note. |
The Motley Fool
February 6, 2009
Brian Orelli |
1,111 Reasons to Love This Company Intuitive Surgical's already installed base of 1,111 da Vinci surgical machines will drive sales through the use of consumables. |
The Motley Fool
January 13, 2012
Dan Caplinger |
Has Intuitive Surgical Become the Perfect Stock? What Intuitive Surgical needs to do to get even closer to perfection is to get to the point in its growth curve at which it's ready to start paying dividends. |
The Motley Fool
October 6, 2010
Jeremy Phillips |
Reasons to Sell Sequenom Today Over the past 12 months, Sequenom has risen 115.7% versus an S&P 500 return of 11.3%. Investors in Sequenom have every reason to be proud of their returns. |
The Motley Fool
December 9, 2011
Marthe LaRosiliere |
Intuitive Surgical: Plenty of Room to Grow The surgical-robot maker is nearly a 10-bagger since 2005, but its future remains bright. |
The Motley Fool
July 23, 2009
Brian Orelli |
The Impressive Number No One Is Talking About Future growth still looks good for Intuitive Surgical. |
The Motley Fool
February 4, 2009
Brian Orelli |
43% Growth! Yee-Haw! Illumina rocks another quarter. |
The Motley Fool
August 16, 2011
Jeremy Phillips |
Read This Before You Think About Selling Sequenom I consider a debt-to-equity ratio below 50% to be healthy, though the number varies by industry. Sequenom is currently below this level, at 1.1%. |
The Motley Fool
June 4, 2010
Brian Richards |
Intuitive Surgical: Strengths, Weaknesses, Opportunities, Threats A look inside the business of the da Vinci robot maker. |
The Motley Fool
November 23, 2005
Rick Munarriz |
Daily Double: Intuitive Surgical While growth investors may not balk at paying 69 times this year's profits for a dynamic growth company like Intuitive Surgical, they may think twice if a bottom line dip prices the company at nearly 80 times forward earnings. |
The Motley Fool
April 23, 2007
Billy Fisher |
Robust Returns in Robotics Intuitive Surgical's da Vinci robot arms reel in profits and shares continue to gain steam. |
American Family Physician
August 15, 2000
David S. Newberger |
Down Syndrome: Prenatal Risk Assessment and Diagnosis |
The Motley Fool
April 24, 2008
Brian Orelli |
Illumina Ignites This biochip maker is on fire. |
The Motley Fool
June 10, 2009
Brian Orelli |
Up 58% on No News? What's Going On? There's no concrete reason for the massive increase in Sequenom yesterday. The stock was flat until noon, then it steadily climbed up to the moon in afternoon trading. |
The Motley Fool
July 25, 2007
Billy Fisher |
Dueling Fools: Intuitive Surgical Bull For a company consistently growing its sales by 50% and maintaining healthy product margins, it's hard to imagine that this medical device maker's stock has yet met its peak. |
The Motley Fool
October 21, 2009
Brian Orelli |
Slicing and Dicing Intuitive Surgical's Quarter Not the best we've seen, but still solid. |
The Motley Fool
February 27, 2011
Anders Bylund |
Buy These 3 Tech Stocks to Hold Forever Google, IBM, and Intuitive Surgical may be those elusive "forever" stocks. |
The Motley Fool
April 17, 2007
Jack Uldrich |
Intuitive Surgical Sells Itself A hospital's mailing on the company's da Vinci Surgical System could boost demand from patients. Investors, take note. |
The Motley Fool
December 30, 2009
Brian Orelli |
The Best Stocks for 2010: Intuitive Surgical Intuitive Surgical never looks cheap. Then again, good growth stocks usually don't. |
The Motley Fool
July 22, 2010
Brian Orelli |
One Surgery Dominated, A Hundred More to Go Intuitive Surgical isn't slowing down. |
The Motley Fool
January 22, 2010
Brian Orelli |
Intuitive Surgical Makes Me a Winner! Hysterectomies are poised to pass prostatectomies as the company's growth driver. |
